Tayal, R. et al. Totally percutaneous insertion and removal of impella device using axillary artery in the setting of advanced peripheral artery disease. J. Invasive Cardiol. 28, 374–380 (2016).
Vasc. Med. 14, 381–392 (2009).
Katsanos, K. et al. Wound healing outcomes and health-related quality-of-life changes in the achilles trial: 1-year results from a prospective randomized controlled trial of infrapopliteal balloon angioplasty versus sirolimus-eluting stenting in patients with ischemic peripheral arterial disease. JACC Cardiovasc. Interv. 9, 259–267 (2016).
J. Am. Coll. Cardiol. 63, 2659–2673 (2014).
Brasen, J. H. et al. Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 21, 1720–1726 (2001).
Acta Biomater. 18, 213–225 (2015).
Worthley, S. G. et al. First-in-human evaluation of a novel polymer-free drug-filled stent: angiographic, IVUS, OCT, and clinical outcomes from the RevElution study. JACC Cardiovasc. Interv. 10, 147–156 (2017).
Nakazawa, G. et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc. Interv. 3, 68–75 (2010).
Ann. Med. 49, 299–309 (2017).
Mol. Ther. 23, 812–823 (2015).
Methods Mol. Biol. 2150, 213–225 (2020).
Vandergriff, A. et al. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics 8, 1869–1878 (2018).
Stem Cell Res. Ther. 8, 273 (2017).
Bone Marrow Transplant. 54, 789–792 (2019).
Front. Cell Dev. Biol. 8, 665 (2020).
Nassar, W. et al. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater. Res. 20, 21 (2016).
Mol. Ther. Nucleic Acids 7, 278–287 (2017).
Stem Cell Res. Ther. 10, 158 (2019).
Tsimikas, S. et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109, 3164–3170 (2004).
Laurindo, F. R. et al. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation 83, 1705–1715 (1991).
Annu. Rev. Immunol. 27, 165–197 (2009).
Circ. Res. 118, 692–702 (2016).
Raines, E. W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int. J. Exp. Pathol. 81, 173–182 (2000).
Su, Z. et al. ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor’s multidrug resistance. J. Control. Release 196, 370–383 (2014).
Cardiovasc. Res. 100, 7–18 (2013).
Am. J. Physiol. 315, H838–H846 (2018).
Stem Cell Res. Ther. 6, 216 (2015).
Surf. Sci. 500, 28–60 (2002).
Draude, F. et al. Characterization of freeze-fractured epithelial plasma membranes on nanometer scale with ToF-SIMS. Anal. Bioanal. 407, 2203–2211 (2015).
Biomaterials 24, 4655–4661 (2003).
Colloid Surf. B 124, 49–68 (2014).
de Gracia Lux, C. et al. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J. Am. Chem. Soc. 134, 15758–15764 (2012).
Starke, R. D. et al. Endothelial von Willebrand factor regulates angiogenesis. Blood 117, 1071–1080 (2011).
Neth. Heart J. 15, 100–108 (2007).
Langeveld, B. et al. Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis. J. Vasc. Res. 41, 377–386 (2004).
Tsai, Y. C. et al. Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in chronic kidney disease. Sci. Rep. 6, 39400 (2016).
Sci. Rep. 7, 44769 (2017).
Douglas, G. et al. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification. Eur. Heart J. 34, 3378–3388 (2013).
J. Tissue Eng. 8, 2041731417731546 (2017).
Trends Biotechnol. 30, 406–409 (2012).
Arterioscler. Thromb. Vasc. Biol. 32, 1104–1115 (2012).
Lee, J. G. et al. Knockout rat models mimicking human atherosclerosis created by Cpf1-mediated gene targeting. Sci. Rep. 9, 2628 (2019).
Cardiovasc. Res. 114, 540–550 (2018).
Br. J. Dermatol. 169, 12–19 (2013).
Yonetsu, T. et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am. J. Cardiol. 110, 933–939 (2012).
J. Angiogenes. Res. 1, 4 (2009).
He, X. et al. MSC-derived exosome promotes M2 polarization and enhances cutaneous wound healing. Stem Cells Int. 2019, 7132708 (2019).
Mahdavi Gorabi, A. et al. The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu. J. Clin. Med. 8, 1413 (2019).
Li, J. et al. Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE−/− mice via miR-let7 mediated infiltration and polarization of M2 macrophage. Biochem. Bioph. Res. Commun. 510, 565–572 (2019).
Atherosclerosis 240, 424–430 (2015).
Koltsova, E. K. et al. Interleukin-27 receptor limits atherosclerosis in Ldlr−/− mice. Circ. Res. 111, 1274–1285 (2012).
Van Weel, V. et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler. Thromb. Vasc. Biol. 27, 2310–2318 (2007).
Arterioscler. Thromb. Vasc. Biol. 22, 1769–1776 (2002).
Vandergriff, A. C. et al. Intravenous cardiac stem cell-derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy. Stem Cells Int. 2015, 960926 (2015).
Qiao, L. et al. MicroRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. J. Clin. Invest. 129, 2237–2250 (2019).
Macromol. Biosci. 16, 635–646 (2016).
Gallet, R. et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur. Heart J. 38, 201–211 (2017).
Zhang, B. et al. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. Cytotherapy 20, 687–696 (2018).
Poh, K. K. et al. Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, ‘off-the-shelf’, cellular cardiomyoplasty strategy. Int. J. Cardiol. 117, 360–364 (2007).
Elnaggar, M. A. et al. Nitric oxide releasing coronary stent: a new approach using layer-by-layer coating and liposomal encapsulation. Small 12, 6012–6023 (2016).
J. Cell Sci. 129, 2182–2189 (2016).
Ferguson, S. W. et al. The microRNA regulatory landscape of MSC-derived exosomes: a systems view. Sci. Rep. 8, 1419 (2018).
Beltrami, C. et al. Human pericardial fluid contains exosomes enriched with cardiovascular-expressed micrornas and promotes therapeutic angiogenesis. Mol. Ther. 25, 679–693 (2017).
Anderson, J. D. et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappa B signaling. Stem Cells 34, 601–613 (2016).
Physiol. Rev. 84, 767–801 (2004).
Lavin, B. et al. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 34, 1739–1746 (2014).
McDonald, R. A. et al. Reducing in-stent restenosis: therapeutic manipulation of mirna in vascular remodeling and inflammation. J. Am. Coll. Cardiol. 65, 2314–2327 (2015).
Yan, W. et al. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation. Theranostics 10, 10712–10728 (2020).
Grasset, E. K. et al. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc. Natl Acad. Sci. USA 112, E2030–E2038 (2015).
Piccolo, R. et al. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet 393, 2503–2510 (2019).
World J. Cardiol. 9, 640–651 (2017).
Huang, P. et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc. Res. 116, 353–367 (2020).
Lim, S. Y. et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. Circ. J. 72, 463–468 (2008).
Liu, F. et al. Hyaluronic acid hydrogel integrated with mesenchymal stem cell-secretome to treat endometrial injury in a rat model of asherman’s syndrome. Adv. Healthc. Mater. 8, 1900411 (2019).
Dinh, P. C. et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat. Commun. 11, 1064 (2020).
Ozbilgin, S. et al. Renal ischemia/reperfusion injury in diabetic rats: the role of local ischemic preconditioning. Biomed. Res. Int. 2016, 8580475 (2016).
Johnson, T. W. et al. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler. Thromb. Vasc. Biol. 25, 754–759 (2005).
Mol. Med. Rep. 15, 21–28 (2017).
Methods Mol. Biol. 1732, 507–517 (2018).